David Amsellem's Stock Ratings

Piper Sandler Analyst

David Amsellem is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024

Overall Average Return

14.5%

Smart Score

68.3%

Overall Average Return Percentile

70th

Number of Ratings

83
Buy NowGet Alert
05/13/2024TEVABuy Now
Teva Pharmaceutical Indus
$16.5420.96%$19 → $20ReiteratesOverweight → OverweightGet Alert
05/10/2024XERSBuy Now
Xeris Biopharma Holdings
$1.9653.06%$4 → $3ReiteratesOverweight → OverweightGet Alert
05/10/2024RVNCBuy Now
Revance Therapeutics
$3.19244.83%$20 → $11ReiteratesOverweight → OverweightGet Alert
05/10/2024COLLBuy Now
Collegium Pharmaceutical
$33.8215.32%$39 → $39DowngradeOverweight → NeutralGet Alert
04/29/2024OGNBuy Now
Organon
$21.3712.31%$22 → $24MaintainsOverweightGet Alert
04/11/2024AQSTBuy Now
Aquestive Therapeutics
$3.23209.63% → $10Initiates → OverweightGet Alert
04/01/2024ALKSBuy Now
Alkermes
$24.3360.3%$39 → $39ReiteratesOverweight → OverweightGet Alert
03/28/2024VTRSBuy Now
Viatris
$11.1117.06%$11 → $13ReiteratesNeutral → NeutralGet Alert
03/21/2024AMRXBuy Now
Amneal Pharmaceuticals
$6.9814.61%$6 → $8MaintainsOverweightGet Alert
03/20/2024JAZZBuy Now
Jazz Pharmaceuticals
$109.9970.92%$171 → $188ReiteratesOverweight → OverweightGet Alert
03/05/2024AVDLBuy Now
Avadel Pharmaceuticals
$16.0942.95%$18 → $23MaintainsOverweightGet Alert
02/29/2024RVNCBuy Now
Revance Therapeutics
$3.19526.96%$42 → $20MaintainsOverweightGet Alert
02/28/2024SUPNBuy Now
Supernus Pharmaceuticals
$28.3644.57%$45 → $41MaintainsOverweightGet Alert
02/23/2024COLLBuy Now
Collegium Pharmaceutical
$33.8215.32%$37 → $39ReiteratesOverweight → OverweightGet Alert
02/16/2024ALKSBuy Now
Alkermes
$24.3360.3%$35 → $39MaintainsOverweightGet Alert
02/16/2024IRWDBuy Now
Ironwood Pharmaceuticals
$6.55220.61%$20 → $21MaintainsOverweightGet Alert
02/12/2024TEVABuy Now
Teva Pharmaceutical Indus
$16.5414.91%$12 → $19UpgradeNeutral → OverweightGet Alert
01/16/2024AXSMBuy Now
Axsome Therapeutics
$75.8948.9%$90 → $113MaintainsOverweightGet Alert
01/03/2024TEVABuy Now
Teva Pharmaceutical Indus
$16.54-27.43%$8 → $12UpgradeUnderweight → NeutralGet Alert
12/07/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.276.45%$33 → $45DowngradeOverweight → NeutralGet Alert
11/22/2023VTRSBuy Now
Viatris
$11.11-0.95%$10 → $11MaintainsNeutralGet Alert
11/22/2023OGNBuy Now
Organon
$21.372.95%$32 → $22MaintainsOverweightGet Alert
11/14/2023CARABuy Now
Cara Therapeutics
$0.7631.6%$12 → $1DowngradeOverweight → NeutralGet Alert
11/10/2023XERSBuy Now
Xeris Biopharma Holdings
$1.96104.08%$5 → $4MaintainsOverweightGet Alert
11/09/2023SUPNBuy Now
Supernus Pharmaceuticals
$28.3651.62%$42 → $43MaintainsOverweightGet Alert
11/09/2023RVNCBuy Now
Revance Therapeutics
$3.191216.61%$44 → $42MaintainsOverweightGet Alert
11/03/2023PCRXBuy Now
Pacira BioSciences
$30.0839.63%$50 → $42MaintainsOverweightGet Alert
11/01/2023NBIXBuy Now
Neurocrine Biosciences
$141.00-29.08%$95 → $100MaintainsNeutralGet Alert
10/27/2023ALKSBuy Now
Alkermes
$24.3343.86%$37 → $35MaintainsOverweightGet Alert
10/25/2023SUPNBuy Now
Supernus Pharmaceuticals
$28.3648.1%$43 → $42MaintainsOverweightGet Alert
10/25/2023OGNBuy Now
Organon
$21.3749.74%$33 → $32MaintainsOverweightGet Alert
10/16/2023HRMYBuy Now
Harmony Biosciences
$29.7041.41%$72 → $42MaintainsOverweightGet Alert
09/28/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.27-21.94% → $33Initiates → OverweightGet Alert
09/20/2023RVNCBuy Now
Revance Therapeutics
$3.191279.31%$50 → $44MaintainsOverweightGet Alert
08/11/2023OPTNBuy Now
OptiNose
$1.17156.41%$4 → $3MaintainsOverweightGet Alert
08/10/2023AVDLBuy Now
Avadel Pharmaceuticals
$16.0911.87%$13 → $18MaintainsOverweightGet Alert
08/09/2023EGRXBuy Now
Eagle Pharmaceuticals
$4.61268.76%$26 → $17DowngradeNeutral → UnderweightGet Alert
08/08/2023CARABuy Now
Cara Therapeutics
$0.761479.16%$13 → $12MaintainsOverweightGet Alert
08/08/2023AXSMBuy Now
Axsome Therapeutics
$75.8918.59%$70 → $90UpgradeNeutral → OverweightGet Alert
08/07/2023AMRXBuy Now
Amneal Pharmaceuticals
$6.98-28.37%$3 → $5MaintainsOverweightGet Alert
08/03/2023CORTBuy Now
Corcept Therapeutics
$27.6112.28%$27 → $31MaintainsOverweightGet Alert
08/03/2023PCRXBuy Now
Pacira BioSciences
$30.0866.22%$60 → $50MaintainsOverweightGet Alert
06/07/2023ALKSBuy Now
Alkermes
$24.3352.08%$35 → $37MaintainsOverweightGet Alert
05/23/2023IRWDBuy Now
Ironwood Pharmaceuticals
$6.55190.08%$16 → $19MaintainsOverweightGet Alert
05/15/2023PCRXBuy Now
Pacira BioSciences
$30.0899.47% → $60MaintainsOverweightGet Alert
05/10/2023SUPNBuy Now
Supernus Pharmaceuticals
$28.3662.2%$45 → $46MaintainsOverweightGet Alert
05/08/2023AMRXBuy Now
Amneal Pharmaceuticals
$6.98-57.02%$5 → $3MaintainsOverweightGet Alert
04/25/2023PCRXBuy Now
Pacira BioSciences
$30.08106.12% → $65MaintainsOverweightGet Alert
04/04/2023CORTBuy Now
Corcept Therapeutics
$27.61-2.21% → $27Initiates → OverweightGet Alert
03/07/2023CARABuy Now
Cara Therapeutics
$0.761610.75%$25 → $13MaintainsOverweightGet Alert
02/07/2023NBIXBuy Now
Neurocrine Biosciences
$141.00-32.63%$103 → $95MaintainsNeutralGet Alert
01/31/2023RVNCBuy Now
Revance Therapeutics
$3.191153.92%$29 → $40MaintainsOverweightGet Alert
01/23/2023SUPNBuy Now
Supernus Pharmaceuticals
$28.3665.73%$40 → $47MaintainsOverweightGet Alert
01/05/2023AXSMBuy Now
Axsome Therapeutics
$75.89-1.17% → $75Initiates → NeutralGet Alert
01/05/2023KRTXBuy Now
Karuna Therapeutics
→ $285Initiates → OverweightGet Alert
01/04/2023HRMYBuy Now
Harmony Biosciences
$29.70135.69%$62 → $70MaintainsOverweightGet Alert
12/07/2022HZNPBuy Now
Horizon Therapeutics
$90 → $110MaintainsOverweightGet Alert
11/23/2022TEVABuy Now
Teva Pharmaceutical Indus
$16.54-57.67%$8 → $7MaintainsUnderweightGet Alert
11/08/2022VTRSBuy Now
Viatris
$11.11-9.95% → $10UpgradeUnderweight → NeutralGet Alert
11/03/2022ALKSBuy Now
Alkermes
$24.3323.3%$26 → $30UpgradeNeutral → OverweightGet Alert
11/02/2022NBIXBuy Now
Neurocrine Biosciences
$141.00-26.95%$91 → $103MaintainsNeutralGet Alert
10/25/2022HZNPBuy Now
Horizon Therapeutics
$90 → $88MaintainsOverweightGet Alert
10/25/2022AMPHBuy Now
Amphastar Pharma
$42.44-5.75%$43 → $40MaintainsOverweightGet Alert
09/09/2022BHCBuy Now
Bausch Health Companies
$7.07-15.11%$7 → $6MaintainsNeutralGet Alert
09/06/2022OGNBuy Now
Organon
$21.3759.1%$37 → $34UpgradeNeutral → OverweightGet Alert
08/31/2022SUPNBuy Now
Supernus Pharmaceuticals
$28.3633.99%$33 → $38MaintainsOverweightGet Alert
08/16/2022ALKSBuy Now
Alkermes
$24.336.86% → $26Initiates → NeutralGet Alert
08/04/2022PCRXBuy Now
Pacira BioSciences
$30.08152.66%$80 → $76MaintainsOverweightGet Alert
07/21/2022PCRXBuy Now
Pacira BioSciences
$30.08165.96%$84 → $80MaintainsOverweightGet Alert
05/25/2022EVFMBuy Now
Evofem Biosciences
$0.0212400%$3750 → $250MaintainsOverweightGet Alert
05/10/2022VTRSBuy Now
Viatris
$11.11-9.95% → $10DowngradeNeutral → UnderweightGet Alert
05/05/2022JAZZBuy Now
Jazz Pharmaceuticals
$109.9975.47%$197 → $193MaintainsOverweightGet Alert
05/04/2022TEVABuy Now
Teva Pharmaceutical Indus
$16.54-57.67%$11 → $7DowngradeNeutral → UnderweightGet Alert
04/22/2022IRWDBuy Now
Ironwood Pharmaceuticals
$6.55144.27% → $16Initiates → OverweightGet Alert
04/14/2022ATRSBuy Now
Antares Pharma
$6 → $5.6DowngradeOverweight → NeutralGet Alert
03/16/2022VTRSBuy Now
Viatris
$11.11-9.95%$17 → $10MaintainsNeutralGet Alert
03/11/2022AMPHBuy Now
Amphastar Pharma
$42.44-17.53%$28 → $35MaintainsOverweightGet Alert
03/03/2022NBIXBuy Now
Neurocrine Biosciences
$141.00-33.34%$114 → $94DowngradeOverweight → NeutralGet Alert
03/02/2022ENDPBuy Now
Endo International
$5 → $3MaintainsNeutralGet Alert
03/02/2022JAZZBuy Now
Jazz Pharmaceuticals
$109.9979.11%$209 → $197MaintainsOverweightGet Alert
02/22/2022COLLBuy Now
Collegium Pharmaceutical
$33.8224.19%$36 → $42MaintainsOverweightGet Alert
02/15/2022BDSIBuy Now
BioDelivery Sciences Intl
$5 → $5.6DowngradeOverweight → NeutralGet Alert
01/07/2022AMPHBuy Now
Amphastar Pharma
$42.44-34.02%$21 → $28UpgradeNeutral → OverweightGet Alert